Vtv Therapeutics Stock Price Prediction

VTVT Stock  USD 13.50  0.10  0.74%   
At this time, The RSI of VTv Therapeutics' share price is at 53. This entails that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling VTv Therapeutics, making its price go up or down.

Oversold Vs Overbought

53

 
Oversold
 
Overbought
The successful prediction of VTv Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with vTv Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting VTv Therapeutics' stock price prediction:
Wall Street Target Price
2
Using VTv Therapeutics hype-based prediction, you can estimate the value of vTv Therapeutics from the perspective of VTv Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in VTv Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying VTv because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

VTv Therapeutics after-hype prediction price

    
  USD 13.43  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out VTv Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VTv Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
3.507.5314.85
Details
Naive
Forecast
LowNextHigh
9.4213.4617.49
Details
2 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

VTv Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of VTv Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VTv Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of VTv Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

VTv Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting VTv Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VTv Therapeutics' historical news coverage. VTv Therapeutics' after-hype downside and upside margins for the prediction period are 9.40 and 17.46, respectively. We have considered VTv Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
13.50
13.43
After-hype Price
17.46
Upside
VTv Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of vTv Therapeutics is based on 3 months time horizon.

VTv Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as VTv Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VTv Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VTv Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.12 
4.03
  0.07 
  0.04 
2 Events / Month
16 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
13.50
13.43
0.52 
683.05  
Notes

VTv Therapeutics Hype Timeline

vTv Therapeutics is at this time traded for 13.50. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.04. VTv is anticipated to decline in value after the next headline, with the price expected to drop to 13.43. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.52%, whereas the daily expected return is at this time at 0.12%. The volatility of related hype on VTv Therapeutics is about 1227.98%, with the expected price after the next announcement by competition of 13.46. About 39.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.99. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. vTv Therapeutics recorded a loss per share of 6.83. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 21st of November 0031. Given the investment horizon of 90 days the next anticipated press release will be in a few days.
Check out VTv Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

VTv Therapeutics Related Hype Analysis

Having access to credible news sources related to VTv Therapeutics' direct competition is more important than ever and may enhance your ability to predict VTv Therapeutics' future price movements. Getting to know how VTv Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VTv Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ZURAZura Bio Limited(0.24)9 per month 3.24  0.07  7.95 (5.46) 20.96 
APGNApexigen(0.02)5 per month 5.50 (0.01) 7.89 (11.11) 58.79 
PHIOPhio Pharmaceuticals Corp(0.05)6 per month 5.13  0.03  11.78 (9.23) 36.22 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
IMMXImmix Biopharma(0.08)3 per month 4.21 (0.03) 9.38 (6.98) 32.68 
SGTXSigilon Therapeutics(5.67)8 per month 6.43  0.11  12.46 (14.07) 442.39 
NBYNovaBay Pharmaceuticals 0.00 5 per month 2.86  0.13  14.29 (5.08) 53.33 
INMInMed Pharmaceuticals 0.01 7 per month 6.02  0.09  10.34 (12.90) 206.11 
GOVXGeoVax Labs(0.34)9 per month 6.81  0.05  16.04 (12.70) 131.31 
GBIOGeneration Bio Co 0.08 5 per month 4.46 (0.02) 9.59 (7.39) 23.41 
KRONKronos Bio(0.03)9 per month 0.00 (0.17) 4.35 (6.25) 15.42 
ERASErasca Inc(0.05)6 per month 3.40  0.07  7.42 (5.19) 17.95 
CCCCC4 Therapeutics(0.08)9 per month 3.69  0  9.57 (7.22) 22.22 
EWTXEdgewise Therapeutics 0.64 7 per month 2.64  0.17  7.17 (4.70) 61.02 
ALLRAllarity Therapeutics 0.03 6 per month 0.00 (0.20) 13.54 (16.11) 41.48 
NRBONeurobo Pharmaceuticals 0.02 6 per month 0.00 (0.11) 6.76 (7.34) 25.62 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.07) 8.33 (7.89) 113.15 
VRAXVirax Biolabs Group(1.38)6 per month 8.68  0.11  50.00 (16.49) 172.66 
QNRXQuoin Pharmaceuticals Ltd(0.02)9 per month 6.86  0.07  17.65 (9.68) 74.46 
PYXSPyxis Oncology(0.02)4 per month 3.19  0.07  6.41 (4.83) 21.67 
CYTOAltamira Therapeutics 0.01 7 per month 0.00 (0.25) 4.48 (8.96) 23.42 
ELEVElevation Oncology 0.00 9 per month 0.00 (0.06) 7.69 (7.69) 17.86 

VTv Therapeutics Additional Predictive Modules

Most predictive techniques to examine VTv price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VTv using various technical indicators. When you analyze VTv charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About VTv Therapeutics Predictive Indicators

The successful prediction of VTv Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as vTv Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of VTv Therapeutics based on analysis of VTv Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to VTv Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VTv Therapeutics's related companies.

Story Coverage note for VTv Therapeutics

The number of cover stories for VTv Therapeutics depends on current market conditions and VTv Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VTv Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VTv Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

VTv Therapeutics Short Properties

VTv Therapeutics' future price predictability will typically decrease when VTv Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of vTv Therapeutics often depends not only on the future outlook of the potential VTv Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VTv Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.1 M
Cash And Short Term Investments9.4 M

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.